Identification and Quantitation of Six Non-Depolarizing Neuromuscular Blocking Agents by LC-MS in Biological Fluids

Journal of Analytical Toxicology

Volumn 28, Issue 2, 2004, Pages 105-110

  Sayer, Hervé ^a   Quintela, Oscar ^b   Marquet, Pierre ^a,d   Dupuy, Jean Louis ^a   Gaulier, Jean Michel ^a   Lachâtre, Gérard ^a,c  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITY OF LIMOGES   (France)

^d DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; AMBENONIUM; AMMONIUM FORMATE; ATRACURIUM; LAUDANOSINE; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; ROCURONIUM; VECURONIUM;

ACCURACY; ACIDIFICATION; ARTICLE; ARTIFICIAL VENTILATION; BLOOD SAMPLING; BODY FLUID; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEVICE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG INFUSION; DRUG SCREENING; HUMAN; LETHALITY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRECIPITATION; QUANTITATIVE ANALYSIS; SUICIDE;

EID: 1542637195     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/28.2.105     Document Type: Article

References (18)

1. H.P. Rang, M.M. Dale, J.M. Ritter. Pharmacology, 4th ed. Churchill Livingstone, Edinburgh, U.K., 2000, pp 125-130
2. U. Nehmer. Simultaneous determination of atracurium besylate and its major decomposition products and related impurities by reversed-phase high-performance liquid chromatography. J. Chromatogr. 435: 425-433 (1988).
3. M. Weindlmayr-Goettel, G. Weberhofer, H. Gilly, and H.G. Kress. Determination of mivacurium in plasma by high-performance liquid chromatography. J. Chromatogr. B 685: 123-127 (1996).
4. M. Zecevic, LJ. Zivanovic, and A. Stojkovic. Validation of a high-performance liquid chromatography method for the determination of pancuronium in Pavulon injections. J. Chromatogr. A 949: 61-64 (2002).
5. J. Ducharme, F. Varin, D.R. Bevan, F. Donati, and Y. Théorê t. High-performance liquid chromatography-electrochemical detection of vecuronium and its metabolites in human plasma. J. Chromatogr. 573: 79-86 (1992).
6. R.J. Simmonds. Determination of atracurium, laudanosine and related compounds in plasma by high-performance liquid chromatography. J. Chromatogr. 343: 431-436 (1985).
7. R.L. Stiller, B.W. Brandom, and D.R. Cook. Determination of atracurium in plasma by high-performance liquid chromatography. Anesth. Analg. 64: 58-62 (1985).
8. T. Furuta, P.C. Canfell, K.P. Castagnoli, M.L. Sharma, and R.D. Miller. Quantitation of pancuronium, 3-desacetylpancuronium, vecuronium, 3-desacetylvecuronium, pipecuronium and 3-desacetylpipecuronium in biological fluids by capillary gas chromatography using nitrogen-sensitive detection. J. Chromatogr. A 427: 41-53 (1988).
9. C. Farenc, C. Enjalbal, P. Sanchez, F. Bressolle, M. Audran, J. Martinez, and J.L. Aubagnac. Quantitative determination of rocuronium in human plasma by liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. A 910: 61-67 (2001).
10. G.J. Dear, J.C. Harrelson, A.E. Jones, T.E. Johnson, and S. Pleasance. Identification of urinary and biliary conjugated metabolites of the neuromuscular blocker 51W89 by liquid chromatography/mass spectrometry. Rapid. Commun. Mass. Spectrom. 9: 1457-1464 (1995).
11. U. Gutteck-Amsler and K.M. Rentsch. Quantification of the aminosteroidal non-depolarizing neuromuscular blocking agents rocuronium and vecuronium in plasma with liquid chromatography-tandem mass spectroscopy. Clin. Chem. 46: 1413-1414 (2000).
12. C.H.M. Kerskes, K.J. Lusthof, P.G.M. Zweipfenning, and J.P. Franke. The detection and identification of quaternary nitrogen muscle relaxants in biological fluids and tissues by ion-trap LC-ESI-MS. J. Anal. Toxicol. 26: 29-34 (2002).
13. C. Farenc, M. Audran, J.Y. Lefrant, I. Mazerm, F. Bressolle. High-performance liquid chromatographic method for the determination of atracurium and laudanosine in human plasma. Application to pharmacokinetics. J. Chromatogr. B 724: 117-126 (1999).
14. V.P. Shah, K.K. Midha, J.W. Findlay, H.M. Hill, J.D. Hulse, I.J. McGilveray, G. McKay, K.J. Miller, R.N. Patnaik, M.L. Powell, A. Tonelli, C.T. Viswanathan, and A. Yacobi. Bioanalytical method validation - a revisit with a decade of progress. Pharm. Res. 17: 1551-1557 (2000).
15. V. Fodale and L.B. Santamaria. Laudanosine, an atracurium and cisatracurium metabolite. Eur. J. Anaesthesiol. 19: 466-473 (2002)
16. R.G. Lawhead, M. Matsumi, K.R. Peters, D.F. Landers, G.L. Becker, R.A. Earl. Plasma laudanosine levels in patients given atracurium during liver transplantation. Anesth. Analg. 73: 569-573 (1993).
17. P. Kintz, A. Tracqui, B. Ludes. The distribution of laudanosine in tissues after death from atracurium injection. Int. J. Legal Med. 114: 93-95 (2000).
18. L. Gao, I. Ramzan, B. Baker. Gas chromatographic-mass spectrometry assay for rocuronium with potential for quantifying its metabolite, 17-desacetylrocuronium, in human plasma. J. Chromatogr. B. 757: 207-214 (2001).